Onkologie und Hämatologie | Zeitschrift memo - Magazine of European Medical Oncology Ausgabe 1/2022 share TEILEN Suchen insite SUCHEN Inhaltsverzeichnis (21 Artikel) 01.02.2022 | editorial Innovative strategies in gastrointestinal cancer Assoc.-Prof. PD Dr. Gerald Prager 01.02.2022 | editorial New frontiers in chronic lymphocytic leukemia on the way to curing the disease Univ.-Prof. Dr. Philipp Staber 01.02.2022 | editorial Toxicity management in severe and refractory cases—what we have learned Univ.-Prof. Dr. Matthias Preusser 03.02.2022 | short review Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner 10.06.2021 | case report Thyroid metastasectomy for deposits from colorectal cancer: case report and non-systematic review Waleed Elnahas, Islam H. Metwally, Wagdi Elkashef 27.01.2022 | short review Immunotherapy—another breakthrough in gastrointestinal malignancies Dr. Monika Lenzi, PD Dr. Thomas Winder PhD Open Access 08.09.2021 | review Neoadjuvant versus adjuvant management of resectable pancreas cancer: A review of the literature PD OA Dr.med.univ. Konstantin Schlick PDF-Version jetzt herunterladen Zum Volltext Open Access 19.10.2021 | short review Innovative strategies in metastatic gastric cancer: a short review Hannah Christina Puhr MD, Aysegul Ilhan-Mutlu MD PhD PDF-Version jetzt herunterladen Zum Volltext 22.12.2021 | short review Practice-changing strategies in the treatment of esophageal cancer Ercan Müldür MD, Wolfgang Hilbe MD 14.01.2022 | short review Treatment decision based on molecular profiling in metastatic colorectal cancer with a focus on RAS pathway mutations Johannes Schöche, Dora Niedersüß-Beke Open Access 22.12.2021 | short review Bcl2 inhibitor venetoclax +/− Anti-CD20: what do deep remissions mean? Katharina T. Prochazka, Barbara Uhl PDF-Version jetzt herunterladen Zum Volltext 20.12.2021 | short review BTKi, venetoclax, obinutuzumab: what is the ideal combination? Daniel Heintel MD Open Access 05.10.2021 | short review New actionable targets and investigational drugs in chronic lymphocytic leukemia Jan-Paul Bohn M.D., PhD PDF-Version jetzt herunterladen Zum Volltext Open Access 09.09.2021 | case report Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab Bernhard Scheiner MD, Matthias Pinter MD PhD PDF-Version jetzt herunterladen Zum Volltext Open Access 06.10.2021 | short review Checkpoint inhibitor pneumonitis: Short review of literature and case report Romana Elisabeth Wass MD, PhD, David Lang MD, PhD, Andreas Horner MD, Bernd Lamprecht MD PDF-Version jetzt herunterladen Zum Volltext Open Access 04.11.2021 | short review Cardiotoxicity—current recommendations of prevention and treatment A.o. Univ. Prof. Jutta Bergler-Klein MD, FESC, FEACVI, FHFA PDF-Version jetzt herunterladen Zum Volltext Open Access 24.11.2021 | short review Clinical challenges in the management of endocrine side effects of immuno-oncological therapies Peter Wolf, Thomas Scherer PDF-Version jetzt herunterladen Zum Volltext 04.01.2022 | case report Palliative care: patient’s autonomy in the end-of-life situation Bert Engelhardt MD 26.10.2021 | case report Chronic myeloid leukemia associated with acquired von Willebrand syndrome: A case report Dr. Prachi Mohapatra MD, Dr. Satya Prasad Mahapatra MD 09.12.2021 | original report The outcome of COVID-19 in patients with hematological malignancy Pınar Tığlıoğlu, Murat Albayrak, Mesut Tığlıoğlu, Hacer Berna Afacan Öztürk, Merih Reis Aras, Buğra Sağlam, Senem Maral 22.11.2021 | original report Clinical characteristics and prognostic value of 1q21 gain detected by fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma Xiao Xiao, Xinchen Fang, Wen Yao, Zhu Huaiping
